Windward Bio AG
Biotechnology Research / Clinical-stage drug developmentPatients with advanced immunological conditions, specifically severe respiratory conditions like asthma and COPD.
Windward Bio AG is a Swiss AG registered in Basel, BS. Its registered activity falls under Activities of holding companies.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Employees~33RevenueNot publicly disclosed; total funding of $365 million reported.Officers6Active Relations6Deleted Relations0SOGC Records5First Record17.06.2024Latest Activity30.07.2025BiotechnologyImmunologyClinical-stage drug developmentRespiratory diseasesBispecific antibodiesTSLP antibody
Registry Information
Renamed 2×
Formerly: LE2024 Therapeutics AG · (LE2024 Therapeutics SA) (LE2024 Therapeutics Ltd)
- Swiss UID
- CHE-272.255.770
- Legal Name
- Windward Bio AG
- Legal Form
- Limited or Corporation
- Incorporated
- 17 Jun 2024
- Share Capital
- CHF 100'000.00
- Canton
- BS
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Activities of holding companies
LFINANCIAL AND INSURANCE ACTIVITIES64Financial service activities, except insurance and pension funding642Activities of holding companies and financing conduits6421Activities of holding companies642100
Industry Health
Registered Address
Aeschenplatz 6
4052, Basel, BS
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Target Customers
Patients with advanced immunological conditions, specifically severe respiratory conditions like asthma and COPD.
Competitors (4)
UCB
Biopharmaceutical company competitors in the immunological and respiratory space.
Cipla
Biopharmaceutical company competitors in the immunological and respiratory space.
Genentech
Biopharmaceutical company competitors in the immunological and respiratory space.
AbbVie
Biopharmaceutical company competitors in the immunological and respiratory space.
